These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5710401)

  • 1. [Favorable clinical and biological action of iron chelator in 4 cases of porphyria cutanea tarda. Attempts at interpretation].
    Beurey J; Weber M; Gurecki H; Perello R; Vadot J
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(5):644-9. PubMed ID: 5710401
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
    Praga M; Enriquez de Salamanca R; Andres A; Nieto J; Oliet A; Perpiña J; Morales JM
    N Engl J Med; 1987 Feb; 316(9):547-8. PubMed ID: 3808000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Porphyria cutanea tarda. Association with scleroderma in patches "brilliant atrophy", calcinosis, hypersideremia, and immunological changes].
    Kaminsky A; Jaimovich L; Kaminsky CA; De Kaminsky AR; Asrilant M; Cammarota H
    Arch Argent Dermatol; 1967 Dec; 17(4):361-9. PubMed ID: 5611068
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of blood ferritin in the evaluation of hepatic siderosis in patients with porphyria cutanea tarda].
    Vozza A; Rossi A; Cicala G; Caso R; Esposito P
    G Ital Dermatol Venereol; 1988; 123(7-8):325-7. PubMed ID: 3224995
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
    Stockenhuber F; Kurz R; Grimm G; Moser G; Balcke P
    Nephron; 1990; 55(3):321-4. PubMed ID: 2370933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
    Muñoz JJ; Garcia-Cabezas J; Martinez-Verano J; Perez-Oteyza C; Enriquez de Salamanca R
    J Dermatol; 1990 May; 17(5):329-31. PubMed ID: 2380437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J; Perrot H; Mallein R; Sabater P
    Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of porphyria cutanea tarda by iron chelators (EDTA, Desferral)].
    Thivolet J; Bondet P; Perrot H; Moene Y
    Lyon Med; 1967 Aug; 218(32):225-30. PubMed ID: 4975716
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphyria cutanea tarda in beta-thalassemia trait carriers.
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Ventura E
    Dermatologica; 1984; 169(3):131-4. PubMed ID: 6479421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic siderosis in porphyria cutanea tarda. (Clinical and pathogenetic considerations)].
    Jean G; Levi L; Ranzi T
    G Ital Dermatol Minerva Dermatol; 1967; 108(6):507-24. PubMed ID: 5632978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Porphyria cutanea tarda with hypersideremia: effectiveness of desferrioxamine (Desferal)].
    Beurey J; Weber M; Montet Y; Jeandidier P; Barbier JM
    Arch Belg Dermatol Syphiligr; 1966; 22(4):235-41. PubMed ID: 6005619
    [No Abstract]   [Full Text] [Related]  

  • 19. [The part of heredity in so-called acquired porphyria cutanea tarda. A familial form].
    Perrot H; Thivolet J
    Ann Dermatol Syphiligr (Paris); 1970; 97(1):5-14. PubMed ID: 5447121
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.